Penn Capital Management Company LLC Acquires New Holdings in Addus HomeCare Corporation $ADUS

Penn Capital Management Company LLC bought a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 25,830 shares of the company’s stock, valued at approximately $2,595,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Global Retirement Partners LLC increased its position in Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after acquiring an additional 186 shares during the period. Larson Financial Group LLC raised its stake in shares of Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares during the last quarter. NFJ Investment Group LLC acquired a new position in shares of Addus HomeCare during the second quarter worth $29,000. Acumen Wealth Advisors LLC acquired a new position in shares of Addus HomeCare during the fourth quarter worth $29,000. Finally, Arax Advisory Partners grew its stake in shares of Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after purchasing an additional 137 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the sale, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.10% of the company’s stock.

Addus HomeCare Trading Down 2.1%

NASDAQ:ADUS opened at $115.55 on Friday. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The firm’s fifty day moving average is $111.95 and its 200-day moving average is $102.96. The firm has a market cap of $2.16 billion, a P/E ratio of 20.27, a P/E/G ratio of 1.55 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. The business had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. Addus HomeCare’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.49 earnings per share. Equities analysts expect that Addus HomeCare Corporation will post 6.3 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ADUS shares. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Barclays lifted their target price on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. Citizens Jmp reiterated a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Finally, Royal Bank Of Canada raised their price objective on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $130.88.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.